Advertisement

The Latest

Centene has appointed Kenneth Tanji to its board of directors, expanding the size of its board to 12. 

In 2019, Medicare spent roughly $7.7 billion on 10 common diabetes drugs, including GLP-1 medications. By 2023, that amount reached $35.8 billion, marking a 364% increase, according to a new report from HHS' Office of Inspector General. 

Advertisement